Literature DB >> 30328575

Is prophylactic cranial irradiation necessary in individuals suffering from surgically resected pT1-2N0M0 small cell lung cancer?

Hongyang Lu1, Zhiming Jiang2, Chenghui Li2.   

Abstract

Adjuvant chemotherapeutics and prophylactic cranial irradiation (PCI) are both recommended in the National Comprehensive Cancer Network (NCCN) guidelines for treating individuals suffering from surgically resected pT1-2N0M0 small cell lung cancer (SCLC). Whether adjuvant chemotherapy combined with PCI is superior to adjuvant chemotherapy alone in these patients is largely unknown. PCI may therefore be with uncertain effects in surgically resected pT1-2N0M0 SCLC.

Entities:  

Keywords:  Adjuvant chemotherapy; Overall survival; Prophylactic cranial irradiation; Small cell lung cancer; Surgical resection

Mesh：

Year:  2018        PMID： 30328575     DOI： 10.1007/s11845-018-1912-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  18 in total

1.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Authors:  A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?

Authors:  Linlin Gong; Q I Wang; Lujun Zhao; Zhiyong Yuan; Ruijian Li; Ping Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-17       Impact factor: 7.038

3.  Prophylactic cranial irradiation improved the overall survival of patients with surgically resected small cell lung cancer, but not for stage I disease.

Authors:  Hui Zhu; Hongbo Guo; Fang Shi; Kunli Zhu; Jingyu Luo; Xibin Liu; Li Kong; Jingming Yu
Journal:  Lung Cancer       Date:  2014-10-16       Impact factor: 5.705

4.  Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).

Authors:  C Le Péchoux; A Laplanche; C Faivre-Finn; T Ciuleanu; R Wanders; D Lerouge; R Keus; M Hatton; G M Videtic; S Senan; A Wolfson; R Jones; R Arriagada; E Quoix; A Dunant
Journal:  Ann Oncol       Date:  2010-12-07       Impact factor: 32.976

5.  Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

Authors:  Aaron H Wolfson; Kyounghwa Bae; Ritsuko Komaki; Christina Meyers; Benjamin Movsas; Cecile Le Pechoux; Maria Werner-Wasik; Gregory M M Videtic; Yolanda I Garces; Hak Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-26       Impact factor: 7.038

6.  Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.

Authors:  Vinai Gondi; Rebecca Paulus; Deborah W Bruner; Christina A Meyers; Elizabeth M Gore; Aaron Wolfson; Maria Werner-Wasik; Alexander Y Sun; Hak Choy; Benjamin Movsas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-04-15       Impact factor: 7.038

7.  Prophylactic cranial irradiation in extensive small-cell lung cancer.

Authors:  Ben Slotman; Corinne Faivre-Finn; Gijs Kramer; Elaine Rankin; Michael Snee; Matthew Hatton; Pieter Postmus; Laurence Collette; Elena Musat; Suresh Senan
Journal:  N Engl J Med       Date:  2007-08-16       Impact factor: 91.245

8.  Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).

Authors:  Hiroshi Yokouchi; Takashi Ishida; Shigeo Yamazaki; Hajime Kikuchi; Satoshi Oizumi; Hidetaka Uramoto; Fumihiro Tanaka; Masao Harada; Kenji Akie; Fumiko Sugaya; Yuka Fujita; Tatsuro Fukuhara; Kei Takamura; Tetsuya Kojima; Toshiyuki Harada; Mitsunori Higuchi; Yoshifumi Matsuura; Osamu Honjo; Yoshinori Minami; Naomi Watanabe; Hiroshi Nishihara; Hiroyuki Suzuki; Hirotoshi Dosaka-Akita; Hiroshi Isobe; Masaharu Nishimura; Mitsuru Munakata
Journal:  Lung Cancer       Date:  2015-10-14       Impact factor: 5.705

9.  Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.

Authors:  Marc Bischof; Jürgen Debus; Klaus Herfarth; Thomas Muley; Jutta Kappes; Konstantina Storz; Hans Hoffmann
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

10.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.